The State of the Pandemic
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
This documentary grasps at straws trying to prove that the former pharmaceutical executive Martin Shkreli might not be as loathsome as his reputation suggests.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
Business interests are using ads and other efforts to cajole Democrats to change or kill a $3.5 trillion social policy bill.
Las píldoras son eficaces y relativamente baratas, pero es poco probable que estén disponibles para todos los enfermos de covid.
The E.U.’s main drug regulator also said that extra doses of the Moderna and Pfizer-BioNTech vaccines can be given to those with underlying health conditions as early as 28 days after the second dose.
The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.
Un número cada vez mayor de pacientes con cáncer, especialmente los de mama y pulmón, se libran del temido tratamiento en favor de otras alternativas.
President Biden’s Covid adviser also says it is “too soon to tell” if the Delta surge will decline enough to allow safe gatherings around the holidays.